425: Merlin Labs to Go Public via $800M SPAC Merger with Bleichroeder
Merger Announcement
Merlin Labs, a developer of AI-enabled autonomous flight technology, will go public through a business combination with Bleichroeder Acquisition Corp. I, valuing Merlin at $800 million pre-money.
Summary
- Merlin Labs, an AI-enabled autonomous flight technology developer, is entering into a definitive business combination agreement with Bleichroeder Acquisition Corp. I (BACQ), a SPAC led by Inflection Point Asset Management.
- The transaction values Merlin Labs at $800 million on a pre-money basis.
- The combined entity is expected to secure over $125 million in committed PIPE capital, with $78 million already funded at the signing of the Business Combination Agreement (BCA) and $50 million committed at closing.
- Bleichroeder Acquisition Corp. I will be renamed Inflection Point Acquisition Corp. IV and will re-domicile from the Cayman Islands to Delaware prior to the closing.
- Existing Merlin Labs shareholders will roll 100% of their interest, retaining at least approximately 62% ownership in the combined company.
- The transaction is anticipated to close in the first quarter of 2026, subject to customary closing conditions, including regulatory and shareholder approvals.
- The proceeds from the transaction will be used to accelerate technology development, expand customer capabilities, enable strategic acquisitions, and retain top talent.
- Merlin Labs projects consolidated revenue of $8.5 million in 2025 and $32 million in 2026, representing a 276% growth.
- Projected gross margin is 33% in 2025 ($2.8 million) and 42% in 2026 ($13.3 million).
- Operating expenses are projected at $39.3 million in 2025 (462% of sales) and $45.5 million in 2026 (142% of sales).
- Research and Development (R&D) expenses are estimated at $27 million in 2025 (318% of sales) and $30.3 million in 2026 (95% of sales).
- Operating cash burn is projected at $(42.3) million in 2025 and total cash burn at $(61.6) million in 2026.
Sentiment
Score: 7
Explanation: The sentiment is positive due to the significant capital raise, strategic positioning in a high-growth sector (AI in aviation for defense and civil applications), strong customer contracts (USSOCOM, USAF), and experienced SPAC sponsor. However, the early-stage nature, historical losses, high projected cash burn, and the inherent risks of a SPAC transaction temper the score, preventing a 'strong buy' recommendation.
Positives
- Merlin Labs is positioned as a leading defense prime contractor for AI in aviation, with a dual-track civil certification program.
- The company has secured a $105 million contract with the United States Special Operations Command (USSOCOM) for C-130J integration and an agreement with the United States Air Force (USAF) for KC-135.
- Merlin Labs has an approved civil certification basis and an active autonomy certification program with the US Federal Aviation Administration (FAA) and NZ Civil Aviation Authority, aiming to be the first to certify an AI skill on an aircraft.
- The company has a proven track record with hundreds of autonomous flight hours across diverse aircraft types (King Air, Cessna, Twin Otter, Long-EZ).
- Strategic partnerships with Northrop Grumman (Model 437 Vanguard testbed) and Honeywell (autonomy for military fleets) enhance capabilities and market reach.
- The transaction is expected to deliver over $125 million in committed capital, with a significant portion ($78 million) already funded, providing immediate growth acceleration.
- The company anticipates unlocking significant savings for customers, potentially billions of dollars for large fleet operators, by implementing the Merlin Pilot.
- Existing Merlin shareholders are rolling 100% of their equity, demonstrating strong confidence in the combined entity's future.
Negatives
- Merlin Labs is an early-stage company with a history of losses and no historical profitability, with projections indicating continued significant cash burn in 2025 and 2026.
- The company's projected operating expenses are very high relative to revenue (462% in 2025, 142% in 2026), indicating a substantial need for capital to scale.
- The valuation of $800 million pre-money is high relative to current and near-term projected revenues, implying significant future growth is already priced in.
- The success of the business is dependent on recruiting, training, and retaining highly skilled employees, which can be challenging in a competitive market.
- Global supply chain challenges, logistics issues, and increasing inflation could adversely affect business, financial condition, and results of operations.
- Significant redemptions by Bleichroeder's public shareholders could reduce the public float and necessitate future financing.
Risks
- Merlin is an early-stage company with a history of losses and may not achieve or maintain profitability in the future.
- The limited operating history and rapid growth make evaluating the current business and future prospects difficult and may increase investment risk.
- Competition could result in price reduction, reduced revenue, and loss of market position.
- Dependence on third-parties for manufacturing equipment components, services, and installation/maintenance poses a risk of disruption.
- Global supply chain challenges, logistics issues, and increasing inflation may adversely affect business.
- Failure to recruit, train, and retain highly skilled employees necessary to remain competitive and execute growth strategy.
- Adverse economic conditions, including economic slowdowns, may have a material adverse effect.
- Uncertain global macro-economic and political conditions could materially adversely affect results.
- Increased attention to climate change, ESG matters, and conservation measures may adversely impact the business.
- Unsuccessful evaluation or pursuit of strategic opportunities could adversely affect revenue and financial condition.
- Regulation by United States and foreign government agencies (FCC, FAA) may increase costs or require changes to services.
- Risk of unsuccessful deployment, maintenance, upgrading, or enhancement of products and services that heavily rely on technology and intellectual property.
- Potential for service interruptions, technology failures, data security incidents, or compromises to controlled/sensitive information.
- Inability of Merlin or its technology suppliers to continue to innovate and provide useful products and services.
- Failure to maintain, protect, or enforce intellectual property rights.
- Exposure to claims of infringing third-party intellectual property rights, leading to significant costs.
- Failure of equipment or material defects/errors in software, firmware, or hardware may damage reputation and result in claims.
- No prior public market for Merlin's Common Stock, and no guarantee that an active and liquid market will develop post-transaction.
- The market price of the Common Stock could fluctuate significantly, resulting in substantial losses.
- Significant portion of total outstanding shares following closing may be sold into the market soon after, potentially causing price drops.
- Inadequate due diligence by Inflection Point could mean material risks are not uncovered.
- Prohibition from entering into certain transactions during the pre-closing period that might otherwise be beneficial.
- Uncertainty regarding approval for listing on Nasdaq or compliance with continued listing standards.
- Legal proceedings in connection with the transaction could delay or prevent completion.
- The grant and future exercise of registration rights may adversely affect the market price of Common Stock.
Future Outlook
Merlin Labs aims to become the operating system of record for aircraft, powering both crewed and uncrewed autonomous flight. The company plans to expand the Merlin Pilot's use across large aircraft (C-130J, KC-135) and smaller drones, leveraging a unified autonomy system. The transaction proceeds are intended to accelerate technology development, expand customer capabilities, enable strategic acquisitions, and retain key talent. Merlin projects significant revenue growth from $8.5 million in 2025 to $32 million in 2026, with improving gross margins, though operating expenses and cash burn are expected to remain substantial as the company scales.
Management Comments
- Matt George, Merlin's CEO and founder, stated, 'We're taking Merlin public to deliver the world's first defense-grade autonomy stack and advance towards delivering the operating system of record for aircraft big and small.'
- George also commented, 'Our national security represents the highest stake proving ground. Defense airframes log over four million flight-hours per year; AI that has earned trust there earns it anywhere.'
- George believes, 'Our entrance into the public market will allow us to double down on our existing customers, expand the volume and types of platforms we support, and accelerate our revenue growth.'
- Michael Blitzer of Inflection Point stated, 'Our transaction with Merlin continues Inflection Point's proven history of identifying leading companies in strategically important industries for the United States, with significant near-term revenue growth potential and a clear path to public market readiness.'
- Blitzer also commented, 'We believe that Merlin is primed to become a national asset that will play a critical role in the future of aerospace and defense for both military and commercial applications.'
Industry Context
Merlin Labs operates at the intersection of aerospace, defense, and artificial intelligence, specializing in AI-enabled autonomous flight technology. The company positions itself as a leader in developing aircraft-agnostic autonomy for national security applications, with a dual-track civil certification program. This places Merlin at the forefront of a rapidly evolving defense landscape, where autonomous capabilities are becoming increasingly critical. The company's focus on both military and civil applications, aiming to be the 'operating system of record for aircraft,' aligns with broader industry trends towards increased automation and AI integration in aviation. Its ability to generate significant cost savings for large fleet customers could be a key differentiator.
Comparison to Industry Standards
- Merlin Labs' pre-money valuation of $800 million is significantly lower than some established or highly-funded autonomy and defense tech peers like Waymo ($45.0 billion), SpaceX ($350.0 billion), and Anduril ($30.5 billion).
- Compared to other publicly traded or recently valued companies in the space, Merlin's valuation is closer to Kodiak ($2.5 billion) and Saronic ($4.0 billion), and higher than Rocket Lab ($21.0 billion) in terms of equity value, but these comparisons are not directly on a revenue multiple basis.
- Merlin's projected 2026 EV/Revenue multiple (approx. 31.25x based on $1000.1M EV and $32M 2026E revenue) falls within the wide range of peer EV/Revenue multiples provided (e.g., 10.8x, 9.7x, 9.1x, 3.3x, 44.0x, 84.5x, 7.2x, 5.6x, 63.1x, 26.5x, 20.0x, 6.1x, 4.9x). This suggests a high growth expectation is embedded in the valuation, consistent with early-stage technology companies in high-potential markets.
- The company's focus on 'takeoff-to-touchdown autonomy' and 'first to certify an AI skill on an aircraft' indicates a pioneering position, potentially justifying a higher valuation multiple compared to more mature or less innovative industry players.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Board of Directors | Current Bleichroeder directors not remaining | Up to seven individuals, two designated by Inflection Point CEO (one independent), remaining by Merlin Labs | At Closing | Restructuring of the board post-business combination |
| Executive Officers | Current Bleichroeder executive officers | Individuals listed on Section 6.19(d) of Company Disclosure Letter and other mutually agreed individuals | Immediately after Closing | Restructuring of executive leadership post-business combination |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | The post-closing board of directors (New Merlin Labs Board) will consist of at most seven individuals, with two designated by Inflection Point's CEO (one independent) and the remainder designated by Merlin Labs. | At Closing | Aligns governance with the new ownership structure, integrating leadership from both the SPAC and the target company. |
| Equity Incentive Plan | A new equity incentive plan will be adopted to grant equity and equity-based awards to eligible service providers of Merlin Labs and its subsidiaries. | Prior to Closing (subject to shareholder approval) | Provides a mechanism for attracting, retaining, and incentivizing key talent post-merger, aligning employee interests with shareholder value. |
| Employee Stock Purchase Plan (ESPP) | An employee stock purchase plan will be adopted to allow eligible employees to participate in stock purchases. | Prior to Closing (subject to shareholder approval) | Enhances employee benefits and encourages broader employee ownership, fostering alignment with company performance. |
| Organizational Documents | Bleichroeder will change its jurisdiction of incorporation to Delaware and adopt new charter and bylaws. Merlin Labs will amend its certificate of incorporation to change its name. | Prior to or concurrent with Closing | Standard procedure for SPAC domestication and target company integration, establishing the legal framework for the combined entity. |
| Preferred Stock Protective Provisions | As long as Inflection Point Asset Management LLC and certain affiliates hold 20% or more of the Series A Preferred Stock, certain actions (e.g., liquidation, adverse charter amendments, creation of senior/pari passu equity, certain redemptions, affiliate transactions, incurring certain indebtedness) require affirmative vote or written consent of a majority of Series A Preferred Stock holders. | At Closing | Provides significant protective rights to key preferred shareholders, influencing major corporate decisions and potentially limiting future financial flexibility. |
Legal Proceedings
- No Legal Proceedings of any nature are currently pending or threatened against any Target Company or its properties/assets, or any of its directors/officers regarding their actions as such, that would be material to the Target Companies as a whole.
- No pending or threatened audits, examinations, or investigations by any Governmental Authority against any Target Company that would be material.
- No pending or written threatened Legal Proceedings by any Target Company against any third party.
- No settlements or similar agreements imposing material ongoing obligations or restrictions on any Target Company.
- No Orders imposed or threatened to be imposed upon any Target Company or its properties/assets, or any of its directors/officers regarding their actions as such, that would be material.
Related Party Transactions
- All agreements with Related Persons (officers, directors, employees, beneficial owners of 5%+ equity, affiliates, immediate family members) are to be terminated or settled at or prior to the Closing without further liability to the Purchaser or the Target Companies, except for employment contracts or Company Benefit Plans made in the ordinary course of business consistent with past practice.
Stakeholder Impact
- **Shareholders (Bleichroeder)**: Will vote on the business combination, domestication, and other proposals. Public shareholders have redemption rights. Existing shareholders will convert their shares into New Merlin Labs Common Stock. Significant redemptions could reduce public float and necessitate future financing.
- **Shareholders (Merlin Labs)**: Existing equity holders will roll 100% of their interest into the combined company, retaining approximately 62% ownership. They will receive New Merlin Labs Common Stock, Series A Preferred Stock, and/or warrants.
- **Employees**: A new equity incentive plan and employee stock purchase plan will be adopted, providing opportunities for equity participation and incentives. Management changes are planned for the combined entity.
- **Customers (Defense)**: Merlin Labs' focus on defense customers (USSOCOM, USAF) and its contracts indicate continued service and expansion of AI-enabled autonomous flight capabilities, potentially leading to significant cost savings for them.
- **Customers (Civil)**: The dual-track civil certification program with FAA and NZ Civil Aviation Authority indicates future expansion into commercial aviation, offering advanced autonomy solutions.
- **Creditors**: Existing indebtedness of Merlin Labs will be paid off at closing, reducing the company's immediate debt burden. New Series A Preferred Stock and convertible notes represent new forms of financing with specific terms (dividends, conversion rights, put/call options).
Next Steps
- Bleichroeder Acquisition Corp. I will change its jurisdiction of incorporation by deregistering as a Cayman Islands exempted company and domesticating as a Delaware corporation (Domestication) prior to the Closing.
- Merlin Labs will change its corporate name to Merlin Labs Operations, Inc. prior to or concurrent with the Domestication.
- Merger Sub will merge with and into Merlin Labs, with Merlin Labs continuing as the surviving company.
- Inflection Point will file a Registration Statement on Form S-4 with the SEC, including a proxy statement/prospectus, for shareholder consideration.
- Inflection Point will convene an extraordinary general meeting of shareholders to approve the Business Combination Agreement, Domestication, new charter/bylaws, issuance of new shares, equity incentive plan, and director nominees.
- Merlin Labs stockholders will provide written consent to approve the Business Combination Agreement and the transactions.
- The parties will work to satisfy customary closing conditions, including regulatory approvals and Nasdaq listing approval for the new common stock.
- Merlin Labs will deliver audited consolidated financial statements for 2024 and 2023 by October 15, 2025, and unaudited statements for H1 2025.
- The combined company will adopt an equity incentive plan and an employee stock purchase plan, and determine initial equity awards for eligible service providers.
- The company will file an effective registration statement on Form S-8 for the equity incentive plan and ESPP shares as soon as practicable after 60 days post-closing.
Key Dates
| Date | Description |
|---|---|
| 2018 | Merlin Labs' Piston aircraft platform was developed. |
| April 24, 2019 | Start date for compliance with economic sanctions, export controls, and money laundering statutes for Target Companies. |
| July 1, 2020 | Amendment date for Merlin Labs' 2018 Equity Incentive Plan. |
| March 17, 2022 | Date of the CRHL Loan agreement between Ministry of Business, Innovation and Employment (now Crown Regional Holdings Limited) and Merlin Labs NZ Limited. |
| October 31, 2024 | Date of Bleichroeder Acquisition Corp. I's initial public offering (IPO) prospectus and the Share Rights Agreement. |
| December 31, 2024 | Fiscal year end for which audited financial statements are being prepared for Merlin Labs; also a reference point for top customer/supplier data and Bleichroeder's Form 10-K filing. |
| March 10, 2025 | Date of Bleichroeder Acquisition Corp. I's Annual Report on Form 10-K filing. |
| March 31, 2025 | End of the six-month period for which draft unaudited consolidated financial statements were provided for Merlin Labs. |
| July 2, 2025 | Merlin Labs entered into Note Purchase Agreements (Pre-PIPE Note Purchase Agreement) with certain accredited investors. |
| July 11, 2025 | Date of Bleichroeder Acquisition Corp. I's Current Report on Form 8-K filing, supplementing director/officer information. |
| August 2025 | Date of the Investor Presentation and Certain Projected Financial Information. |
| August 13, 2025 | Signing Date of the Business Combination Agreement, Sponsor Support Agreement, and Securities Purchase Agreement (Series A SPA). |
| August 14, 2025 | Date of the press release announcing the Business Combination Agreement and the signing date of the 8-K filing. |
| June 30, 2025 | End of the six-month period for which unaudited consolidated financial statements (Updated 1H Financial Statements) will be delivered for Merlin Labs. |
| October 15, 2025 | Deadline for Merlin Labs to deliver audited consolidated financial statements for 2024 and 2023 to Bleichroeder. |
| First quarter of 2026 | Expected closing timeframe for the Business Combination. |
| August 13, 2026 | Outside Date for the Business Combination Agreement termination if closing has not occurred. |
Recommendation
holdThe business combination with Merlin Labs presents a compelling opportunity in the high-growth, strategically important sector of AI-enabled autonomous flight, particularly given its strong defense contracts and dual-track civil certification efforts. The significant PIPE funding provides a solid capital base for future development. However, Merlin Labs is an early-stage company with a history of losses and substantial projected cash burn, indicating high execution risk. The pre-money valuation is aggressive relative to current revenues, relying heavily on future growth and market penetration. While the long-term potential is significant, the immediate financial profile and inherent risks associated with scaling a deep-tech company in a regulated industry warrant a 'hold' recommendation. Investors should monitor execution, cash burn, and progress towards profitability and broader market adoption.
Keywords
Autonomous Flight, AI in Aviation, Defense Technology, Aerospace, SPAC Merger, Merlin Labs, Inflection Point, USSOCOM, USAF, C-130J, KC-135, FAA Certification, NZ Civil Aviation Authority, Machine Learning, Avionics, Public Company, PIPE Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.